Search

Author/Creator Beaumont, M.

12. T cell activation and anti-tumor efficacy of anti-Lag3 mAbs are independent of Lag-3–MHC Class II blocking capacity. (December 2016)

Authors:
De Waal Malefyt, R.; Zhao, S.; Haines, B.; Chenard, M.; Laskey, J.; Cui, L.; Blumenschein, W.; Churakova, T.; Shukla, R.; Hsieh, E.; Beaumont, M.; Fayadat-Dilman, L.; Cemerski, S.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S98
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. VP37.15: Third trimester placental 3DPD quantification is feasible only for non‐posterior placentas: first results from the prospective EVUPA study1. (15th October 2020)

Authors:
Gabriel, P.; Duan, J.; Hossu, G.; Cherifi, A.; Dap, M.; Beaumont, M.; Ambroise‐Grandjean, G.; Bertholdt, C.; Perdriolle‐Galet, E.; Morel, O.
Journal:
Ultrasound in obstetrics & gynecology
Issue:
Volume 56(2020)Supplement 1
Page Start:
220
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗